Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Isis obtains antisense cancer rights from Genzyme Molecular Oncology

Dec. 28, 1998

First convincing data for extended therapeutic gene expression by human stem cells

Dec. 28, 1998

In vivo safety and efficacy of photodynamic therapy evaluated by Theratechnologies in CML patients

Dec. 28, 1998

Gliadel Wafer approved in Canada and France

Dec. 28, 1998

New cancer-linked gene licensed by Corixa from MIT

Dec. 23, 1998

Preliminary phase II results for Incel + paclitaxel in refractory breast cancer

Dec. 23, 1998

Orphan drug status given to Immunomedics' CEA-Cide pancreatic cancer therapeutic

Dec. 23, 1998

Phase I results with GI-147211 establish MTD; phase II doses recommended

Dec. 22, 1998

Isis and Zeneca to develop novel antisense-based cancer drugs

Dec. 22, 1998

Campto launched in another major market

Dec. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.